Drug details
Dengvaxia (dengue vaccine)
type of Vaccines, Live, Viral
Dengvaxia (dengue tetravalent vaccine, live) is a vaccine indicated for the prevention of dengue disease caused by dengue virus serotypes 1, 2, 3 and 4. Dengvaxia is approved for use in individuals 9 through 16 years of age with laboratory-confirmed previous dengue infection and living in endemic areas.
This drug may have the following side effects:
- headache,
- weakness,
- fever, and
- muscle pain
- injection site reactions (pain, redness, swelling),
- feeling unwell (malaise),
The following drugs are related to Dengvaxia, either as a replacement or used together:
- Tylenol (acetaminophen)
- Motrin (ibuprofen)